Prof Alexander Tenenbaum
Alexander Tenenbaum graduated with a medical degree and a PhD in the former Soviet Union. He then became a cardiologist at the Sheba Medical Center, Tel Hashomer, Israel. Currently, he is Scientific Director of Cardiac Rehabilitation Institute, Sheba Medical Center, Tel Hashomer and Associate Professor of Cardiology at Tel-Aviv University, Israel. His research interests and areas of expertise include clinical cardiology, echocardiography, hypertension, heart failure, cardiovascular drug therapy and computed tomography. During recent years he has become especially involved in the research of various aspects of the dyslipidemia, metabolic syndrome, obesity and the diabetes/cardiovascular interrelationship. Prof. Tenenbaum is the author of hundreds scientific publications including monograph "Cardiovascular Diabetology: Clinical, Metabolic and Inflammatory Facets" (Basel, Karger 2008). Since 2002, he has served as an Editor-in-Chief of Cardiovascular Diabetology (BioMed Central, London). Prof. Tenenbaum is Co-Founder and Chairmen of The Israeli Working Group on Cardiovascular Pharmacology and Drug Therapy (IHS) and Governor of the International Society of Cardiovascular Pharmacotherapy (ISCP).
A strong correlation between cardiovascular disease and diabetes is now well established. The American Heart Association considers that individuals with insulin resistance or diabetes are more likely to fall victim to heart disease or stroke. Cardiovascular Diabetology is the world’s foremost journal specifically devoted to this issue. Submitted manuscripts may report any aspect of laboratory, animal, or human research related to diabetes and its cardiovascular complication.
